U.S. Strikes Friday Killed Three Colombians, Hegseth Says—After Trump Calls Colombian President A ‘Drug Leader’

In a show of solidarity, European leaders are rallying behind Ukrainian President Volodymyr Zelenskyy following a tense meeting with former U.S. President Donald Trump. The EU is actively working to secure a deal on frozen Russian assets and implement additional sanctions against Moscow. This is significant as it highlights the EU's commitment to supporting Ukraine amidst ongoing tensions, reinforcing international unity against aggression.

In a recent statement, former President Trump has pledged to maintain significant tariffs on India until the country halts its imports of Russian oil. This move highlights ongoing tensions in international trade and energy policies, as it could impact economic relations between the U.S. and India, and further complicate global oil markets. Trump's stance reflects a broader strategy to pressure nations into aligning with U.S. foreign policy, particularly regarding Russia's actions.

China's economic growth has slowed down to 4.8% in the latest quarter, a decline from 5.2% in the previous quarter. This slowdown is attributed to ongoing trade tensions with the US and persistent issues in the property market. The decrease in growth is concerning as it reflects fragile domestic demand, which could have broader implications for global markets and trade relationships. Understanding these dynamics is crucial as they may affect not only China's economy but also the global economic landscape.

Stock traders are feeling optimistic as the possibility of Trump losing his tariff war gains traction. With investors believing that the Federal Reserve's rate cuts are secure, the potential ruling from the U.S. Supreme Court declaring Trump's tariffs illegal could further boost the market. This situation is significant as it not only impacts stock prices but also reflects broader economic sentiments, making it a pivotal moment for traders.

US equity futures are on the rise as investors are shifting their attention from trade tensions and credit concerns to upcoming earnings reports. President Trump has outlined key trade demands with China, focusing on rare earths, fentanyl, and soybeans, just as crucial trade talks approach. Meanwhile, Paul Donovan from UBS is weighing in on the Federal Reserve's interest rate strategy amid a prolonged government shutdown. This shift in focus could signal a more optimistic outlook for the markets, making it an important moment for investors.

President Trump's influence in the ongoing tariff war is diminishing as China's economy shows stronger-than-expected growth, surpassing forecasts. This development is significant because it indicates that China is successfully diversifying its exports, potentially reducing the impact of U.S. tariffs. As the economic landscape shifts, it raises questions about the effectiveness of Trump's trade policies and their long-term implications for U.S.-China relations.

President Trump's focus on rare earths highlights ongoing tensions with China as the trade truce approaches its end, raising concerns for global markets. Meanwhile, France faces economic challenges with a second credit downgrade from S&P, which could impact investor confidence. In a significant move, Kering's new CEO, Luca de Meo, is selling the beauty division to L’Oréal for $4.7 billion, signaling a shift in strategy for the luxury brand. These developments are crucial as they reflect broader economic trends and the interconnectedness of global trade.

A recent analysis of Polymarket data reveals that betting against Donald Trump could be a profitable strategy. Timothy L. O’Brien from Bloomberg Opinion highlights how placing a bet on TACO for the 2025 election would have yielded returns. This insight is significant as it not only showcases the potential of prediction markets but also provides a unique perspective on political forecasting.

Cleveland-Cliffs is experiencing a surge in demand for its steel products, thanks in part to favorable trade policies from the Trump administration that support U.S. manufacturing. The company is also looking to diversify its operations by exploring the production of rare-earth minerals, which are crucial for various high-tech applications. This move not only strengthens its market position but also highlights the growing importance of domestic production in the face of global supply chain challenges.

Kering has announced a significant $4.7 billion deal to sell its beauty business to L’Oréal, marking a strategic move by the new CEO, Luca de Meo, to rejuvenate the company's performance. This sale is crucial as it allows Kering to focus on its core luxury brands while L’Oréal expands its portfolio in the beauty sector. Such a transaction not only reflects the evolving landscape of luxury and beauty but also highlights Kering's commitment to strengthening its market position.

Amazon's AWS experienced significant disruptions, leading to outages for hundreds of websites for several hours. This incident highlights the vulnerability of online services that rely on cloud infrastructure, affecting businesses and users alike. The impact of such outages can be far-reaching, causing loss of revenue and frustrating users who depend on these platforms for daily activities.

Crude oil prices are continuing to decline due to concerns over supply and demand. Factors such as weak growth projections, the ongoing energy transition in China and the EU, and tensions from U.S.-China tariffs are contributing to this negative outlook. This matters because fluctuations in oil prices can significantly impact global economies and consumer behavior.

Merck has released long-term data demonstrating that its cancer treatment, KEYTRUDA, continues to provide significant survival benefits for patients with lung cancer. This is important because it reinforces the effectiveness of KEYTRUDA as a vital option in cancer therapy, potentially improving the quality of life for many patients facing this challenging disease.

Abbvie's stock price target has been raised to $258 from $240 by BMO Capital, reflecting growing confidence in the company's future performance. This adjustment is significant as it indicates analysts' optimism about Abbvie's potential for growth and profitability, which could attract more investors and positively impact the stock market.